# Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

Study · id `cardio:ct-nct03336528` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03336528](<https://clinicaltrials.gov/study/NCT03336528>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03336528

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT03336528. Randomized; no masking; primary purpose treatment. Start 2018-01-02 (actual); primary completion 2021-03-01 (actual). Results posted on 2022-03-31.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Started: 2018-01-02 (actual) (ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Primary completion: 2021-03-01 (actual) (ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Completion: 2021-03-01 (actual) (ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Results first posted: 2022-03-31 (ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03336528, source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03336528-2022-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Drug): Degludec
- Intervention (Drug): Glargine
- Intervention (Drug): Aspart
- Lead sponsor: Emory University
- Lead sponsor class: OTHER
- Collaborator: Novo Nordisk A/S
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Emory University (`cardio:org-emory-university`)
- Registry lists this organization as a collaborator: Novo Nordisk (`cardio:novo-nordisk`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes (`cardio:pubmed-34490700`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9f29476871c8cb176f570bd5ad17060968c8ba0ea4e5c61176e578eed7a17a60
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
